Foye's principles of medicinal chemistry / Victoria F. Roche, S. William Zito... [y otros 44 autores].
Idioma: Inglés Philadelphia : Wolters Kluwer , 2020Edición: 8th editionDescripción: xix, 1626 páginas : ilustracionesTipo de contenido:- text
- unmediated
- volume
- 9781496385024
- Principles of medicinal chemistry
- 615.19 P957m 2020
| Tipo de ítem | Biblioteca actual | Colección | Signatura topográfica | Copia número | Estado | Fecha de vencimiento | Código de barras | |
|---|---|---|---|---|---|---|---|---|
| Libros | Biblioteca Ciencias de la Salud Estantería | General | 615.19 P957m 2020 (Navegar estantería(Abre debajo)) | c.1 | Disponible | 004707 | ||
| Libros | Biblioteca Ciencias de la Salud Estantería | General | 615.19 P957m 2020 (Navegar estantería(Abre debajo)) | c.2 | Disponible | 004708 | ||
| Libros | Biblioteca Ciencias de la Salud Estantería | General | 615.19 P957m 2020 (Navegar estantería(Abre debajo)) | c.3 | Disponible | 004709 | ||
| Libros | Biblioteca Ciencias de la Salud Estantería | General | 615.19 P957m 2020 (Navegar estantería(Abre debajo)) | c.4 | Disponible | 004710 | ||
| Libros | Biblioteca Ciencias de la Salud Estantería | General | 615.19 P957m 2020 (Navegar estantería(Abre debajo)) | c.7 | Prestado | 29/10/2024 | 008137 |
Incluye índice.
Incluye referencias bibliográficas al final de cada capítulo.
PART I: PRINCIPLES / Chapter 1. Introduction to Medicinal Chemistry.- Chapter 2. Fundational Principles and Functional Goup Impavt on Activity.- Chapter 3. Drug Metabolism.- Chapter 4. Membrane Drug Transporters.- Chapter 5. Principles of Biotechnology-Derived Drugs.
PART II: RECEPTOR TARGETS / Chapter 6. G. Protein-Coupled Receptors.- Chapter 7. Nuclear Receptors.- Chapter 8. Ion Channel Receptors.- Chapter 9. Enzyme/Catalytic Receptors.
PART III: PHARMACODYNAMIC AGENTS.
Section I: Drugs impacting the central nervous system / Chapter 10. Drugs Used to Treat Neuromuscular Disorders.- Chapter 11. Drugs Used to Treat Mental, Bahavioral, and Cognitive Disorders.- Chapter 12. Drugs Used to Induce/Support Sedation or Anesthesia.- Chapter 13. Drugs Used to Treat Seizure Disorders.
Section 2: Drugs impacting pain perception / Chapter 14. Drugs Used to Treat Pain: Centrally Acting Agents.- Chapter 15. Drugs Used to Treat Pain: Peripherally Acting Agents.
Section 3: Drugs impacting the cardiovascular system / Chapter 16. Drugs Used to Treat Cardiac Disorders.- Chapter 17. Drugs Used to Treat Hupertensive/Hipotensive Disorders.- Chapter 18. Drugs Used to Treat Coagulation Disorders.- Chapter 19. Drugs Used to Treat Dyslipidemic Disorders.
Section 4: Drugs impacting hormonal systems / Chapter 20. Drugs Used to Treat Diabetic Disorders.- Chapter 21. Drugs Used to Treat Inflammatory and Corticosteroid Deficiency Disorders.- Chapter 22. Drugs Used to Treat Thyroid Disorders.- Chapter 23. Drugs Used to Treat Calcium-Dependent Disorders.- Chapter 24. Drugs Used to Advance Men's and Women's Health.
Section 5: Drugs impacting immune, gastrointestinal and genitourinary systems / Chapter 25. Drugs Used to Treat Allergic Disorders.- Chapter 26. Drugs Used to Treat Gastrointestinal and Genitourinary Disorders.
Section 6: Drugs impacting ocular, nasal and pulmonary systems / Chapter 27. Drugs Used to Treat Ocular and Nasal Congestion Disorders.- Chapter 28. Drugs Used to Treat Pulmonary Disorders.
Section 7: Drugs impacting infectious and neoplastic disease processes / Chapter 29. Drugs Used to Treat Bacterial Infections.- Chapter 30. Drugs Used to Treat Viral Infections.- Chapter 31. Drugs Used to Treat Fungal Infections.- Chapter 32. Drugs Used to Treat Parasitic Infections.- Chapter 33. Drugs Used to Treat Neoplastic Diseases.
Section 8: Therapeutic biologics / Chapter 34. Biologic Used in the Treatment of Disease.
PART IV: DISEASE STATE MANAGEMENT / Chapter 35. Coronary Artery Disease.- Chapter 36. Rheumatoid Arthritis.- Chapter 37. Nutrition and Obesity.-